Mutations in FBNs and/or their associated proteins are responsible for connective tissue disorders that are associated with microfibril and elastic fiber fragmentation and dysregulated TGF-β signaling affecting skeletal, ocular, cardiac, and respiratory systems (11, 23, 29, 44, 55). This evidence concerns the gene TGFB1 and connective tissue disorder.